Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy of Lipid-containing Artificial Tears in the Treatment of Dry Eye
Sponsor: University Hospital Sestre Milosrdnice
Summary
This clinical study involves patients with Dry Eye Disease (DED) who are visiting an ophthalmology outpatient clinic. Eligible participants must have an Ocular Surface Disease Index (OSDI) score ≥14 and \<50, and at least one positive diagnostic test: tear break-up time (TBUT) \<7 seconds, Schirmer I test \<10 mm/5 min, or positive corneal staining based on the Oxford grading scale. At baseline, tear film thickness will be measured using Pentacam imaging. Participants will then receive Proluxx eye spray, applied four times daily for 28 days. After this treatment period, a follow-up examination with all baseline assessments will be repeated.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2025-04-25
Completion Date
2025-09
Last Updated
2025-05-02
Healthy Volunteers
No
Interventions
Proluxx Artificial Tear Spray
Topical artificial tear spray applied to closed eyelids four times daily for 28 days.
Locations (1)
UHC Sestre milosrdnice
Zagreb, City of Zagreb, Croatia